Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Corporate Action-Outcome of Sub division / Stock Split

 7. The Board considered the proposal for sub-division of 1 equity share of the Company having face value of Rs.10/- each into 10 (Ten) equity shares having face value of Rs.1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company. Further, the Board recommended consequential amendments in the Capital Clause of the Memorandum of Association of the Company and Articles of Association of the Company, subject to approval of the Shareholders of the Company. The record date for the sub-division of equity shares shall be decided by the Board and will be intimated to the exchanges. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 9, 2015 is enclosed herewith as Annexure ll.
13-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Fixed Record Date For ( Dividend )

 6.The Register of Members and Share Transfer Books of the Company will remain closed for payment of dividend and AGM from Saturday 02nd September , 2023 to Saturday 09th September , 2023 (both days inclusive). The Dividend on Ordinary (Equity) Shares for the year ended 31st March, 2023, as recommended by the Board of Directors and as may be declared at the AGM, will be paid/dispatched on or after Saturday 09th September , 2023 to those Shareholders or their mandates:
13-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements), 2015.

 Dear Sir / Madam, Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a consolidated basis for the half year ended 31st March, 2023 Kindly take the same on your records.
13-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Financial Results For March 31, 2023 (Annually)

 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2023. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I)
13-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th May, 2023

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2023. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2023 of Rs. 5/- i.e. @ 50% per equity share having face value of Rs.10/- aggregating to Rs. 4,60,13,850/-. The payment is subject to the approval of shareholders at the ensuing AGM. 3. Appointment of M/s. B.J. D. Nanabhoy & Co., as the Cost Auditors of the Company for the FY 2023-24.
13-05-2023
Bigul

Annual report for Themis Medicare Ltd. for FY-2023
13-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The Company is scheduling Earning Conference Call on Monday, 15th May 2023 at 12:00 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.
08-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Intimation Of Date Of Board Meeting & Closure Of Trading Window.

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Saturday, 13.05.2023 inter alia, to transact the following business: 1.To consider the Audited Financial Results for the Quarter/Year ended on 31.03.2023, 2.To consider recommending Dividend if any on the equity shares of the Company for the financial year 2022-23. 3.To consider and approve the proposal to sub-divide/split the Equity Shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required.
04-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule Ill to the said Regulations, we wish to inform that Dr. Gabor Gulasci Non-Executive Non-Independent Director (DIN: 06975242 ), has resigned from the position of the Director of the Company with effect from 02nd May, 2023. Consequent upon resignation of Dr. Gabor Gulasci, the office of Mrs. Reena Patel (DIN: 00228669 ), Alternate director to Dr. Gabor Gulasci also gets vacated pursuant to section 161 of Companies Act,2013 and she ceases to be an Alternate Director with effect from 02nd May, 2023. We have annexed herewith the disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 relating to change in Directors of the Company as Annexure I.
02-05-2023
Bigul

THEMIS MEDICARE LTD. - 530199 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyTHEMIS MEDICARE LTD. 2CIN NO.L24110GJ1969PLC001590 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 20.38 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sangameshwar Iyer Designation: Company secretary and Compliance Officer EmailId: sangameshwar.iyer@themismedicare.com Name of the Chief Financial Officer: Tushar Dalal Designation: Chief Financial officer EmailId: tushar.dalal@themismedicare.com Date: 28/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
28-04-2023
Next Page
Close

Let's Open Free Demat Account